Medicare, the government-backed program for adults aged 65 and older and those with disabilities, only covers the use of GLP-1 drugs for diabetes, but not for weight loss. Spending on older medicines ...
Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...
The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.
People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
Scripps News on MSN23h
Hims and Hers likely to stop selling cheaper versions of GLP-1 medicationsThe FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...
A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...
Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...
Ramadan often presents a security challenge in Jerusalem, but this may be greater this year given the ongoing seven-front war and Operation Iron Wall in the West Bank. Information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback